advertisement
Huang P 11
Showing records 1 to 11 | Display all abstracts from Huang P117897 Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study
Shalaby WS; Shalaby WS; Shalaby WS
Ophthalmology. Glaucoma 2024; 7: 251-259
117517 Resveratrol Ameliorates Retinal Ischemia-Reperfusion Injury by Modulating the NLRP3 Inflammasome and Keap1/Nrf2/HO-1 Signaling Pathway
Feng J
Molecular Neurobiology 2024; 61: 8454-8466
117897 Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study
Reddy R; Reddy R
Ophthalmology. Glaucoma 2024; 7: 251-259
117517 Resveratrol Ameliorates Retinal Ischemia-Reperfusion Injury by Modulating the NLRP3 Inflammasome and Keap1/Nrf2/HO-1 Signaling Pathway
Ji K
Molecular Neurobiology 2024; 61: 8454-8466
117897 Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study
Wummer B
Ophthalmology. Glaucoma 2024; 7: 251-259
117517 Resveratrol Ameliorates Retinal Ischemia-Reperfusion Injury by Modulating the NLRP3 Inflammasome and Keap1/Nrf2/HO-1 Signaling Pathway
Pan Y; Huang P
Molecular Neurobiology 2024; 61: 8454-8466
117897 Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study
Huang P
Ophthalmology. Glaucoma 2024; 7: 251-259
117517 Resveratrol Ameliorates Retinal Ischemia-Reperfusion Injury by Modulating the NLRP3 Inflammasome and Keap1/Nrf2/HO-1 Signaling Pathway
He T
Molecular Neurobiology 2024; 61: 8454-8466
117897 Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study
Lee D
Ophthalmology. Glaucoma 2024; 7: 251-259
117517 Resveratrol Ameliorates Retinal Ischemia-Reperfusion Injury by Modulating the NLRP3 Inflammasome and Keap1/Nrf2/HO-1 Signaling Pathway
Xing Y
Molecular Neurobiology 2024; 61: 8454-8466
117897 Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study
Razeghinejad R; Pro MJ
Ophthalmology. Glaucoma 2024; 7: 251-259
